C4 Therapeutics
CCCC
CCCC
118 hedge funds and large institutions have $1.15B invested in C4 Therapeutics in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
+5
Holders Change %
+4.42%
% of All Funds
1.82%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
21
Increased
42
Reduced
33
Closed
16
Calls
$1.9M
Puts
–
Net Calls
+$1.9M
Net Calls Change
-$2.73M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$29.6M |
| 2 |
Millennium Management
New York
|
$24.3M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
$57.1M |
| 4 |
BlackRock
New York
|
$110M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
$32.1M |
